These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10959408)

  • 1. Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland.
    Tonner E; Allan G; Shkreta L; Webster J; Whitelaw CB; Flint DJ
    Adv Exp Med Biol; 2000; 480():45-53. PubMed ID: 10959408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal control of plasmin and tissue-type plasminogen activator activity in rat milk during involution of the mammary gland.
    Tonner E; Allan GJ; Flint DJ
    J Endocrinol; 2000 Nov; 167(2):265-73. PubMed ID: 11054640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding proteins initiate cell death and extracellular matrix remodeling in the mammary gland.
    Flint DJ; Boutinaud M; Tonner E; Wilde CJ; Hurley W; Accorsi PA; Kolb AF; Whitelaw CB; Beattie J; Allan GJ
    Domest Anim Endocrinol; 2005 Aug; 29(2):274-82. PubMed ID: 15998501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland.
    Flint DJ; Tonner E; Allan GJ
    J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):65-73. PubMed ID: 10791769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin.
    Sorrell AM; Shand JH; Tonner E; Gamberoni M; Accorsi PA; Beattie J; Allan GJ; Flint DJ
    J Biol Chem; 2006 Apr; 281(16):10883-9. PubMed ID: 16505491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IGFBP-5 in mammary gland development and involution.
    Allan GJ; Beattie J; Flint DJ
    Domest Anim Endocrinol; 2004 Oct; 27(3):257-66. PubMed ID: 15451073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat.
    Tonner E; Barber MC; Travers MT; Logan A; Flint DJ
    Endocrinology; 1997 Dec; 138(12):5101-7. PubMed ID: 9389489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.
    Tonner E; Barber MC; Allan GJ; Beattie J; Webster J; Whitelaw CB; Flint DJ
    Development; 2002 Oct; 129(19):4547-57. PubMed ID: 12223411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prolactin, growth hormone and insulin-like growth factor 1 in mammary gland involution in the dairy cow.
    Accorsi PA; Pacioni B; Pezzi C; Forni M; Flint DJ; Seren E
    J Dairy Sci; 2002 Mar; 85(3):507-13. PubMed ID: 11949853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene.
    Flint DJ; Boutinaud M; Whitelaw CB; Allan GJ; Kolb AF
    J Mol Endocrinol; 2006 Jun; 36(3):435-48. PubMed ID: 16720715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does an IGF-binding protein (IGFBP) present in involuting rat mammary gland regulate apoptosis?
    Tonner E; Quarrie L; Travers M; Barber M; Logan A; Wilde C; Flint D
    Prog Growth Factor Res; 1995; 6(2-4):409-14. PubMed ID: 8817684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival.
    Flint DJ; Knight CH
    J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):41-8. PubMed ID: 10887518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the actions of IGFs by IGFBP-5 in the mammary gland.
    Flint DJ; Beattie J; Allan GJ
    Horm Metab Res; 2003; 35(11-12):809-15. PubMed ID: 14710362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, acting in part through the insulin-like growth factor axis, rescues developmental, but not metabolic, activity in the mammary gland of mice expressing a single allele of the prolactin receptor.
    Allan GJ; Tonner E; Barber MC; Travers MT; Shand JH; Vernon RG; Kelly PA; Binart N; Flint DJ
    Endocrinology; 2002 Nov; 143(11):4310-9. PubMed ID: 12399427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells.
    Lochrie JD; Phillips K; Tonner E; Flint DJ; Allan GJ; Price NC; Beattie J
    J Cell Physiol; 2006 May; 207(2):471-9. PubMed ID: 16419030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal control of IGF-binding protein (IGFBP)-5 and IGFBP-2 secretion during differentiation of the HC11 mouse mammary epithelial cell line.
    Phillips K; Park MA; Quarrie LH; Boutinaud M; Lochrie JD; Flint DJ; Allan GJ; Beattie J
    J Mol Endocrinol; 2003 Aug; 31(1):197-208. PubMed ID: 12914536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells.
    Marshman E; Green KA; Flint DJ; White A; Streuli CH; Westwood M
    J Cell Sci; 2003 Feb; 116(Pt 4):675-82. PubMed ID: 12538768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed mammary gland involution in mice with mutation of the insulin-like growth factor binding protein 5 gene.
    Ning Y; Hoang B; Schuller AG; Cominski TP; Hsu MS; Wood TL; Pintar JE
    Endocrinology; 2007 May; 148(5):2138-47. PubMed ID: 17255210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone suppresses the expression of IGFBP-5, and promotes the IGF-I-induced phosphorylation of Akt in bovine mammary epithelial cells.
    Sakamoto K; Yano T; Kobayashi T; Hagino A; Aso H; Obara Y
    Domest Anim Endocrinol; 2007 May; 32(4):260-72. PubMed ID: 16698222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells.
    Fleming JM; Brandimarto JA; Cohick WS
    J Endocrinol; 2007 Aug; 194(2):349-59. PubMed ID: 17641284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.